Implementation of solutions to reduce opioid-induced oversedation and respiratory depression

被引:16
|
作者
Meisenberg, Barry [1 ,2 ]
Ness, John [3 ]
Rao, Sumati [3 ]
Rhule, Jane [2 ]
Ley, Cathaleen [4 ]
机构
[1] Anne Arundel Med Ctr, Ctr Hlth Care Improvement, Annapolis, MD 21401 USA
[2] Anne Arundel Med Ctr, Res Inst, Outcomes Dept, Annapolis, MD 21401 USA
[3] Anne Arundel Med Ctr, Dept Pharm, Annapolis, MD USA
[4] Anne Arundel Med Ctr, Dept Nursing Qual & Res, Annapolis, MD USA
关键词
analgesics; opioid; narcosis; narcotics; patient safety; PAIN MANAGEMENT; SEDATION ASSESSMENT; ADVERSE-EVENTS; PATIENT SAFETY; CARE-UNIT; HYDROMORPHONE; ANESTHESIA;
D O I
10.2146/ajhp160208
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The implementation of interventions to mitigate the causes of opioid-induced oversedation and respiratory depression (OSRD) is reported. Summary. A single-site retrospective review of eligible rescue naloxone cases was conducted to identify the causes of opioid-induced OSRD in a hospital as well as to identify risk factors. A survey was used to assess potential opioid knowledge deficits among hospitalist prescribers. Based on the findings of the case reviews and results of the opioid knowledge assessments, a series of interventions to address noted deficiencies was implemented over the ensuing months, including enhanced monitoring for sedation, improved clinical decision support in the electronic medical record (EMR), and various adjustments to dosing for high-risk patients. The primary endpoint of our analysis was naloxone use for documented cases of opioid-induced OSRD to determine the effectiveness of the interventions. A mean of 16 OSRD events occurred per quarter before intervention implementation. An average of five risk factors (range, two to six) was found among OSRD cases, most commonly age of >60, obesity, and comorbidities of the kidneys and lungs. Deficiencies of clinical care were found in four inter-related domains: knowledge deficits, inadequate monitoring, failure to leverage the EMR, and cultural issues regarding pain assessments and sedation management. Conclusion. Implementation of solution bundles that utilized an EMR to create meaningful clinical decision support and cultural changes related to pain goals and communication about sedation level at an acute care hospital resulted in a fivefold reduction in OSRD events that has been sustained for two years.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 50 条
  • [31] Monitoring for Opioid-Induced Respiratory Depression: Review of New Evidence
    Jungquist, Carla R.
    PAIN MANAGEMENT NURSING, 2017, 18 (02) : 65 - 65
  • [32] Pupillometer to Predict Postoperative Opioid-Induced Respiratory Depression in Children
    Oliver, Jeffrey
    Abramson, Charles
    Privitera, Claudio
    Sadhasivam, Senthilkumar
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [33] Opioid-Induced Respiratory Depression: Is Hydromorphone Safer Than Morphine?
    Roth, Jonathan V.
    ANESTHESIA AND ANALGESIA, 2021, 132 (04): : E60 - E60
  • [34] Multi-Level Regulation of Opioid-Induced Respiratory Depression
    Palkovic, Barbara
    Marchenko, Vitaliy
    Zuperku, Edward J.
    Stuth, Eckehard A. E.
    Stucke, Astrid G.
    PHYSIOLOGY, 2020, 35 (06) : 391 - 404
  • [35] Postoperative Opioid-induced Respiratory Depression A Closed Claims Analysis
    Lee, Lorri A.
    Caplan, Robert A.
    Stephens, Linda S.
    Posner, Karen L.
    Terman, Gregory W.
    Voepel-Lewis, Terri
    Domino, Karen B.
    ANESTHESIOLOGY, 2015, 122 (03) : 659 - 665
  • [36] Genetic variation regulates opioid-induced respiratory depression in mice
    Bubier, Jason A.
    He, Hao
    Philip, Vivek M.
    Roy, Tyler
    Hernandez, Christian Monroy
    Bernat, Rebecca
    Donohue, Kevin D.
    O'Hara, Bruce F.
    Chesler, Elissa J.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [37] Serotonin therapies for opioid-induced disordered swallow and respiratory depression
    Frazure, Michael
    Morimoto, In
    Fielder, Nathan
    Mellen, Nicholas
    Iceman, Kimberly
    Pitts, Teresa
    JOURNAL OF APPLIED PHYSIOLOGY, 2024, 136 (04) : 821 - 843
  • [38] Genetic variation regulates opioid-induced respiratory depression in mice
    Jason A. Bubier
    Hao He
    Vivek M. Philip
    Tyler Roy
    Christian Monroy Hernandez
    Rebecca Bernat
    Kevin D. Donohue
    Bruce F. O’Hara
    Elissa J. Chesler
    Scientific Reports, 10
  • [39] Association Between Race and Opioid-Induced Respiratory Depression: An International Post Hoc Analysis of the Prediction of Opioid-induced Respiratory Depression In Patients Monitored by Capnography Trial
    Sim, Ming Ann
    Seet, Edwin
    Khanna, Ashish K.
    Weingarten, Toby N.
    Liew, Lydia
    Law, Lawrence Siu-Chun
    Liu, Katherine E.
    Di Piazza, Fabio
    Ti, Lian Kah
    ANESTHESIA AND ANALGESIA, 2022, 135 (05): : 1097 - 1105
  • [40] Opioid-induced respiratory depression: clinical aspects and pathophysiology of the respiratory network effects
    Baldo, Brian A.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2025, 328 (02) : L267 - L289